Immediate Impact
3 from Science/Nature 78 standout
Citing Papers
Biomarkers in Cancer Detection, Diagnosis, and Prognosis
2023 Standout
N6-methyladenosine regulated FGFR4 attenuates ferroptotic cell death in recalcitrant HER2-positive breast cancer
2022 Standout
Works of A. Stopeck being referenced
Phase II trial of the Hsp90 inhibitor tanespimycin (Tan) + trastuzumab (T) in patients (pts) with HER2-positive metastatic breast cancer (MBC)
2008
Presence of circulating tumor cells (CTC) in metastatic breast cancer (MBC) predicts rapid progression and poor prognosis
2005
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| A. Stopeck | 236 | 80 | 86 | 20 | 287 | |
| Loretta D’Onofrio | 133 | 78 | 76 | 18 | 291 | |
| Marie‐Therese Haider | 229 | 56 | 84 | 16 | 323 | |
| Songran Liu | 141 | 91 | 73 | 27 | 317 | |
| Ferdinand Haslbauer | 207 | 77 | 52 | 26 | 287 | |
| Issei Hirai | 114 | 113 | 64 | 27 | 272 | |
| Shengyu Wu | 119 | 67 | 67 | 26 | 314 | |
| Jewel Plummer Cobb | 135 | 72 | 65 | 20 | 322 | |
| Congrong Liu | 63 | 48 | 68 | 29 | 300 | |
| Pengfei Jiang | 127 | 109 | 40 | 21 | 320 | |
| Valentina Magri | 196 | 60 | 124 | 27 | 324 |
All Works
Loading papers...